• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

• 药品评价-临床研究 • 上一篇    下一篇

莫沙必利联合黛力新治疗功能性消化不良的效果评价

杜尚春,秦建平   

  1. 成都市新都区第三人民医院,成都市新都区第三人民医院
  • 收稿日期:2017-11-17 修回日期:2017-11-17 出版日期:2017-12-25 发布日期:2017-12-25

Evaluation of Mosapride Combined with Deanxit in the Treatment of Functional Dyspepsia Effect

Du Shangchun and   

  1. Third People''s Hospital of Xindu District, Chengdu,Third People''s Hospital of Xindu District, Chengdu
  • Received:2017-11-17 Revised:2017-11-17 Online:2017-12-25 Published:2017-12-25

摘要: 目的:评价莫沙必利联合黛力新在功能性消化不良患者中的临床治疗效果。结果:选取成都市新都区第三人民医院92例功能性消化不良患者,采用双盲法纳入分组,观察组(n=46)给予莫沙必利+黛力新疗法,对照组(n=46)给予莫沙必利,对比2组患者治疗效果。结果:观察组与对照组患者临床治疗总有效率(95.65% vs 76.09%)对比存在明显差异(P<0.05);观察组恶心、呕吐、嗳气、腹痛等症状消失时间均低于对照组(P<0.05);观察组用药不良反应发生率(6.52%)低于对照组(23.91%),组间数据对比存在明显差异(P<0.05)。结论:莫沙必利联合黛力新临床效果确切,能够进一步提高临床疗效,改善患者临床症状,用药安全有效。

Abstract: Objective: To investigate the clinical effect of Mosapride combined with Deanxit in patients with functional dyspepsia. Methods:92 patients with functional dyspepsia in Chengdu Third people′s Hospital of Xindu District were selected and divided into two groups by double blind method, observation group (n=46) treated with Mosapride plus Deanxit therapy. The control group (n=46) treated with Mosapride, compared 2 groups of patients the effect. Results:The observation group and the control group of patients with clinical total effective rate (95.65% vs 76.09%) there were obvious differences between (P<0.05). Observation group were nausea and vomiting, belching, abdominal pain and other symptoms disappeared time were lower than the control group (P<0.05). The incidence of adverse reactions in the observation group (6.52%) than in the control group (23.91%). There are obvious differences in data between the two groups (P<0.05).Conclusion: The clinical effect of Mosapride combined with Deanxit is effective, can improve the clinical effect, improve clinical symptoms, safe and effective medication.